ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2026
Potential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional Network.
Kirsten Werner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.